Seroprevalence of HIV, HBV, HCV & RPR among cornea donor in the regional institute of ophthalmology
Journal of Integrated Health Sciences · 2017 · 5 (1) · 39
DOI: 10.4103/2347-6486.240223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrated Health Sciences, 2017. Verfasst von MH Patel und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Donor corneas obtained by eye banks are steadily increasing all over the world. Proper evaluation of donor cornea is critical to the success of cornea transplantation.
Objectives
To analyse results of screening test done before corneal tissue transplantation.
Methods
Blood samples were collected at the time of enucleation of the eye from 947 consecutive cornea donors. The samples were tested for Antibodies of Human Immunodeficiency virus I & II (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV) & Treponema pallidum.
Results
In our study sero-prevalence of HIV, HBV, HCV & T. pallidum in eye donors are 1.58%, 0.52%, 0.10 and 0.21% respectively.
Conclusion
The study suggests that all the cornea donors should be screened for HIV, HBV, HCV & T. pallidum by serological test like standards followed in Blood banks of India.
Zitieren
APA
Patel, M., Patel, A., & Shah, A. (2017). Seroprevalence of HIV, HBV, HCV & RPR among cornea donor in the regional institute of ophthalmology. Journal of Integrated Health Sciences, 5(1), 39. https://doi.org/10.4103/2347-6486.240223
Vancouver
Patel M, Patel A, Shah A. Seroprevalence of HIV, HBV, HCV & RPR among cornea donor in the regional institute of ophthalmology. Journal of Integrated Health Sciences. 2017;5(1):39. doi:10.4103/2347-6486.240223
BibTeX
@article{Patel2017,
author = {Patel, MH and Patel, AM and Shah, AM},
title = {Seroprevalence of HIV, HBV, HCV & RPR among cornea donor in the regional institute of ophthalmology},
journal = {Journal of Integrated Health Sciences},
year = {2017},
volume = {5},
number = {1},
pages = {39},
doi = {10.4103/2347-6486.240223}
}
EUVIMED